• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】50411

【品名】ethyl (E)-3-[4-(benzyloxy)phenyl]-2-ethoxy-2-propenoate

【CA登记号】

【 分 子 式 】C20H22O4

【 分 子 量 】326.39228

【元素组成】C 73.6% H 6.79% O 19.61%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(XIII)

The condensation of 4-(benzyloxy)benzaldehyde (XII) with phosphonium salt (V) by means of TMG as before gives the acrylic ester (XIII), which is hydrogenated with H2 over Rh/C in methanol to yield the propionic ester (XIV). The hydrolysis of (XIV) with LiOH in dioxane/water affords the corresponding acid (XV) as a racemic mixture, which is condensed with (R)-phenylglycinol (IX) by means of EDC, HOBt and DIEA in dichloromethane to provide the amide (XVI) as a diastereomeric mixture that is separated by crystallization and chromatography. The desired (S)-isomer (XVII) is treated with H2SO4 in hot dioxane/water to furnish the chiral propionic acid (XVIII), which is esterified with EtOH and HCl to give the ethyl propionate (XIX). The hydrogenolysis of the benzyl ether group of (XIX) with H2 over Pd/C in ethyl acetate yields the phenolic derivative (XX), which is condensed with the bis-methanesulfonate by means of K2CO3 in acetonitrile to afford the adduct (XXI). Finally, the ester group of (XXI) is hydrolyzed with LiOH in THF/water to provide the target propionic acid.

1 McIntyre, J.A.; Castaner, J.; Bayes, M.; Tesaglitazar. Drugs Fut 2003, 28, 10, 959.
2 Andersson, K.; Boije, M.; Inghardt, T.; Lindstedt Alstermark, E.-L.; Gottfries, J.; Li, L. (AstraZeneca plc); New 3-aryl-2-aryl propionic acid derivs. and analogs. EP 1084101; EP 1084102; EP 1084103; WO 9962870; WO 9962871; WO 9962872 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(II) 50403 4-[2-[(methylsulfonyl)oxy]ethyl]phenyl methanesulfonate C10H14O6S2 详情 详情
(V) 50405 (Ethoxy(ethoxycarbonyl)methyl)triphenylphosphonium chloride C24H26ClO3P 详情 详情
(IX) 14376 (2R)-2-amino-2-phenyl-1-ethanol; (R)-(-)-2-phenylglycinol; (R)-2-amino-2-phenyl-1-ethanol 56613-80-0 C8H11NO 详情 详情
(XII) 29179 4-(Benzyloxy)benzaldehyde 4397-53-9 C14H12O2 详情 详情
(XIII) 50411 ethyl (E)-3-[4-(benzyloxy)phenyl]-2-ethoxy-2-propenoate C20H22O4 详情 详情
(XIV) 50412 ethyl 3-[4-(benzyloxy)phenyl]-2-ethoxypropanoate C20H24O4 详情 详情
(XV) 50413 3-[4-(benzyloxy)phenyl]-2-ethoxypropionic acid C18H20O4 详情 详情
(XVI) 50414 3-[4-(benzyloxy)phenyl]-2-ethoxy-N-[(1R)-2-hydroxy-1-phenylethyl]propanamide C26H29NO4 详情 详情
(XVII) 50415 (2S)-3-[4-(benzyloxy)phenyl]-2-ethoxy-N-[(1R)-2-hydroxy-1-phenylethyl]propanamide C26H29NO4 详情 详情
(XVIII) 40516 methyl (1R,5R)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylate C10H15NO2 详情 详情
(XIX) 50417 ethyl (2S)-3-[4-(benzyloxy)phenyl]-2-ethoxypropanoate C20H24O4 详情 详情
(XX) 50418 ethyl (2S)-2-ethoxy-3-(4-hydroxyphenyl)propanoate C13H18O4 详情 详情
(XXI) 50419 ethyl (2S)-2-ethoxy-3-[4-([4-[(methylsulfonyl)oxy]phenethyl]oxy)phenyl]propanoate C22H28O7S 详情 详情

合成路线2

该中间体在本合成路线中的序号:(IIIa)

Several related procedures have been described for the synthesis of the title compound. The Horner-Emmons reaction of 4-benzyloxybenzaldehyde (I) with triethyl 2-ethoxyphosphonoacetate (II) afforded the unsaturated ester (IIIa-b) as a mixture of E/Z isomers. Simultaneous double-bond hydrogenation and benzyl group hydrogenolysis in the presence of Pd/C furnished phenol (IV). Alternatively, double-bond reduction by means of magnesium in MeOH was accompanied by transesterification, yielding the saturated methyl ester (V). Further benzyl group hydrogenolysis of (V) over Pd/C gave phenol (VI). The alkylation of phenols (IV) and (VI) with the phenoxazinylethyl mesylate (VII) provided the corresponding ethers (VIII) and (IX), respectively. The racemic carboxylic acid (X) was then obtained by hydrolysis of either ethyl- (VIII) or methyl- (IX) esters under basic conditions.

1 Kalchar, S.; Lohray, V.B.; Lohray, B.B.; Chakrabarti, R.; Bajji, A.C.; Ramanujam, R. (Dr. Reddy's Research Foundation); Novel tricyclic cpds. and their use in medicine; process for their preparation and pharmaceutical compsns. containing them. EP 1049684; JP 2001519422; WO 9919313 .
2 Rajagopalan, R.; Ashok, C.B.; Shivaramayya, K.; Gurram, R.M.; Lohray, B.B.; Paraselli, B.R.; Rajan, C.; Lohray, V.B. (Dr. Reddy's Research Foundation); Novel tricyclic cpds. and their use in medicine; process for their preparation and pharmaceutical compsn. containing them. EP 1155006; WO 0050414 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IIIa) 50411 ethyl (E)-3-[4-(benzyloxy)phenyl]-2-ethoxy-2-propenoate C20H22O4 详情 详情
(IIIb) 51683 ethyl (Z)-3-[4-(benzyloxy)phenyl]-2-ethoxy-2-propenoate C20H22O4 详情 详情
(I) 29179 4-(Benzyloxy)benzaldehyde 4397-53-9 C14H12O2 详情 详情
(II) 51675 ethyl 2-(diethoxyphosphoryl)-2-ethoxyacetate C10H21O6P 详情 详情
(IV) 51682 ethyl 2-ethoxy-3-(4-hydroxyphenyl)propanoate C13H18O4 详情 详情
(V) 51676 methyl 3-[4-(benzyloxy)phenyl]-2-ethoxypropanoate C19H22O4 详情 详情
(VI) 51677 methyl 2-ethoxy-3-(4-hydroxyphenyl)propanoate C12H16O4 详情 详情
(VII) 51678 2-(10H-phenoxazin-10-yl)ethyl methanesulfonate C15H15NO4S 详情 详情
(VIII) 51679 ethyl 2-ethoxy-3-[4-[2-(10H-phenoxazin-10-yl)ethoxy]phenyl]propanoate C27H29NO5 详情 详情
(IX) 51680 methyl 2-ethoxy-3-[4-[2-(10H-phenoxazin-10-yl)ethoxy]phenyl]propanoate C26H27NO5 详情 详情
(X) 51681 2-ethoxy-3-[4-[2-(10H-phenoxazin-10-yl)ethoxy]phenyl]propionic acid C25H25NO5 详情 详情
Extended Information